Why the study?
Data were lacking on the reliability and clinical relevance of cardiac implantable electronic device telemonitoring systems in patients with single ventricle anatomy after Fontan palliation reaching adulthood.
Does telemonitoring of epimyocardial CIEDs provide clinically relevant data to guide therapy in patients with a single ventricle anatomy?
Does telemonitoring of epimyocardial CIEDs provide clinically relevant data to guide therapy in patients with a single ventricle anatomy?
Telemonitoring of epimyocardial CIEDs in patients with a single ventricle anatomy provides clinically actionable data that led to therapeutic interventions in 44% of patients.
Answers are grounded in this paper and cite their sources.
May support telemonitoring to guide therapy in single-ventricle CIED patients; hypothesis-generating and requires prospective validation.
BACKGROUND: A growing number of patients with a single ventricle anatomy, who had a Fontan palliation as a child, are now reaching adulthood. Many need an epimyocardial pacemaker system with an optional telemonitoring (TM) unit, which evaluates the collected data and sends it via Internet to the patient's physician. There are no data on the reliability and clinical relevance of these systems in this patient group. METHODS: We analyzed data in 48 consecutive patients (mean age 18 years, standard deviation 9 years) with a Fontan or Fontan-like palliation who received a cardiac implantable electronic device with a TM unit from Biotronik (Home Monitoring) or Medtronic (CareLink) between 2005 and 2020 with regard to the reliability and clinical relevance of the downloaded data. RESULTS: The observation period was from 4 months to 14 years (mean 7 years, standard deviation 3.9 years). A total of 2.9 event messages (EMs)/patient/month and 1.3 intracardiac electrogram recordings/patient/month were received. Two patients died during follow-up. The combination of regularly arriving statistical data and 313 clinically relevant EMs led to the modification of antiarrhythmic or diuretic medication, hospitalization with cardioversion or ablation, and cortisone therapy to avoid exit block in 21 (44%) patients. CONCLUSION: TM is an instrument to receive functional and physiologic parameters of our Fontan patients. It provides the ability to respond early for signs of system failure, or arrhythmia, even if the patient is not experiencing any problems. It is a useful tool to manage this difficult patient population without frequent hospital visits.
No takes yet. Share an insight, caveat, or question.
Zartner et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: